Our events calendar includes details of learning opportunities, webinars and training courses organised by ourselves, our partners, charities and other organisations working to improve cancer outcomes.
It also provides information and resources to support cancer awareness events throughout the year.
Simply scroll through the months or use the search bar below to find an event which interests you. If you would like to include a training event, please contact the cancer alliance via our administration email: rsch.sscaadmin@nhs.net
Sept 01
1 September 2024 to 30 September 2024
September is Blood Cancer Awareness Month. Find resources to raise awareness about signs and symptoms for the public, community settings and healthcare professionals here.
Sept 01
1 September 2024 to 30 September 2024
September is Gynaecological Cancer Awareness Month. Find resources for the public, patients and healthcare professionals here.
Sept 01
1 September 2024 to 30 September 2024
September is Urology Cancer Awareness Month. Find information packs for the public and community settings to raise awareness about urological cancer signs and symptoms, plus guides and training for healthcare professionals.
Sept 17
17 September 2024, 9:00 am to 10:15 am
As the intermittent shortages of PERT continues across the UK, it’s important that all health professionals have accurate, expert guidance to support patients during this challenging time.
Join Pancreatic Cancer UK on 17th September for our free morning webinar exploring the PERT shortage guidance for health professionals.
Sept 17
17 September 2024, 9:00 am to 4:30 pm
This in-person, one-day event is a chance to share ideas, network and hear about work focused on improving cancer pathways across Frimley, Surrey and Sussex.
Sept 17
17 September 2024, 2:00 pm to 4:00 pm
An interactive Session Introducing New Acute Oncology Updates.
Sept 18
18 September 2024, 12:00 pm to 2:30 pm
This online event is for members of PCN administration teams and anyone working within breast cancer screening settings. It will support increased uptake, address health inequalities and support improved access experience and outcomes.
Sept 24
24 September 2024, 9:00 am to 4:00 pm
This event is for healthcare professionals looking to enhance their knowledge and skills in this area. Don't miss out on this opportunity to learn from experts in the field and network with peers.
Sept 27
27 September 2024
This year's UK Acute Oncology Society Conference takes place at the Birmingham Conference & Events Centre. This year's theme is `Transforming acute oncology - everyone's business'.
Oct 01
1 October 2024 to 31 October 2024
Oct 01
1 October 2024 to 31 October 2024
Stoptober is a national smoking cessation campaign led by Public Health England that encourages smokers to start by abstaining from smoking for 28 days during the month of October.
Oct 02
2 October 2024, 9:00 am to 10:30 am
Throughout October, Pancreatic Cancer UK is holding a series of free webinars exploring some of the common symptoms of pancreatic cancer and how to manage these. The events are suitable for all healthcare professionals working closely with people with pancreatic cancer.
Oct 03
3 October 2024, 9:30 am to 12:30 pm
Introducing progress made in developing novel immunotherapies for solid tumours, emphasising the progress made in CAR T cell therapy, TCR-engineered T cell therapy, tumour infiltrating lymphocytes, T cell engagers, and vaccine-based treatments. In particular, Dr Vickers will describe cancers where novel immunotherapies are being most intensively explored, such as in the treatment of:
• cancers already known to be sensitive to immunotherapy, such as melanoma skin cancer
• cancers where new treatments are desperately needed, such as pancreatic cancer and glioblastoma
• cancers where a particularly promising target has been identified, such as Claudin 18.2 in stomach cancer and other GI cancers
Oct 08
8 October 2024, 9:00 am to 10:45 am
Throughout October, Pancreatic Cancer UK is holding a series of free webinars exploring some of the common symptoms of pancreatic cancer and how to manage these. The events are suitable for all healthcare professionals working closely with people with pancreatic cancer.
Oct 12
12 October 2024
Shine Cancer Support is a charity providing support and information for adults with cancer in their 20s, 30s and 40s.
Oct 13
13 October 2024
Shine Cancer Support is a charity providing support and information for adults with cancer in their 20s, 30s and 40s.
Oct 16
16 October 2024, 9:00 am to 10:30 am
Throughout October, Pancreatic Cancer UK is holding a series of free webinars exploring some of the common symptoms of pancreatic cancer and how to manage these. The events are suitable for all healthcare professionals working closely with people with pancreatic cancer.
Oct 16
16 October 2024, 12:00 pm to 1:00 pm
The share & learn is for all GP administration staff who are undertaking the cancer screening uptake improvement work, or are interested to understand more.
Oct 16
16 October 2024, 1:00 pm to 2:00 pm
Surrey and Sussex Cancer Alliance has teamed up with NHS South East Genomic Medicine Service to host two online sessions for primary care colleagues working across the South East. The webinars aim to increase understanding about genomic medicine and how it can benefit both healthcare professionals and their patients.
Oct 22
22 October 2024, 9:30 am to 12:30 pm
During this morning session Dr Vickers explores the relationship between cancer and the immune system and how cancer cells evade and suppress white blood cells to stay alive. We explore how immune checkpoint inhibitors such as nivolumab and pembrolizumab hope to boost the cancer-fighting response from the person’s immune system and also cover the critical features of T lymphocytes and why they’re the focus of these treatments, as well as many other forms of immunotherapy such as treatment vaccines, oncolytic viruses, double-ended proteins called T cell engagers, TIL (tumour-infiltrating lymphocyte) therapy, and CAR T cells.
Oct 24
24 October 2024, 9:00 am to 10:30 am
Throughout October, Pancreatic Cancer UK is holding a series of free webinars exploring some of the common symptoms of pancreatic cancer and how to manage these. The events are suitable for all healthcare professionals working closely with people with pancreatic cancer.
Nov 01
1 November 2024 to 30 November 2024
More information to come
Nov 01
1 November 2024 to 30 November 2024
Nov 06
6 November 2024, 1:00 pm to 2:00 pm
Surrey and Sussex Cancer Alliance has teamed up with NHS South East Genomic Medicine Service to host two online sessions for primary care colleagues working across the South East. The webinars aim to increase understanding about genomic medicine and how it can benefit both healthcare professionals and their patients.
Nov 12
12 November 2024, 4:00 pm to 5:00 pm
The fundamental idea of precision medicine is to offer each cancer patient a treatment approach that is tailored to the unique biology and genetics of their disease.
First we are introduced to the scientific concepts that underpin the concept of precision medicine looking at the features of cancer cells that we can target, the treatments available, and the tests and technologies needed to match targets with treatments. Includes the example of non-squamous, nonsmall cell lung cancer, where a precision approach is often already used.
Secondly we focus on the limitations and current realities of precision medicine exploring why it isn’t always possible, or might not give the best outcome, for every patient. We close by exploring progress made in offering a precision-approach with three of the most common cancers: breast, bowel, and prostate, and considering where we go from here.
Nov 15
15 November 2024, 4:00 pm to 5:00 pm
The fundamental idea of precision medicine is to offer each cancer patient a treatment approach that is tailored to the unique biology and genetics of their disease.
First we are introduced to the scientific concepts that underpin the concept of precision medicine looking at the features of cancer cells that we can target, the treatments available, and the tests and technologies needed to match targets with treatments. Includes the example of non-squamous, nonsmall cell lung cancer, where a precision approach is often already used.
Secondly we focus on the limitations and current realities of precision medicine exploring why it isn’t always possible, or might not give the best outcome, for every patient. We close by exploring progress made in offering a precision-approach with three of the most common cancers: breast, bowel, and prostate, and considering where we go from here.
Nov 27
27 November 2024, 8:30 am to 5:00 pm
This study day is designed to support the need of understanding the Ambulatory Care framework and the benefit of having the service.
Dec 10
10 December 2024, 9:30 am to 12:30 pm
Delivered over two morning sessions, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will guide you through many of the most relevant topics relating to modern systemic treatments for non-small cell lung cancer (NSCLC).
The first session will focus on the gene faults that drive many NSCLCs and on the targeted treatments that exploit these faults, such as inhibitors of EGFR, ALK, ROS1, B-Raf, HER2, MET and RET.
The second explores cancer’s relationship with the immune system and on the checkpoint inhibitor group of immunotherapies, which include PD-1, PD-L1 and CTLA-4 targeted antibody therapies.
Dec 13
13 December 2024, 9:30 am to 12:30 pm
Delivered over two morning sessions, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will guide you through many of the most relevant topics relating to modern systemic treatments for non-small cell lung cancer (NSCLC).
The first session will focus on the gene faults that drive many NSCLCs and on the targeted treatments that exploit these faults, such as inhibitors of EGFR, ALK, ROS1, B-Raf, HER2, MET and RET.
The second explores cancer’s relationship with the immune system and on the checkpoint inhibitor group of immunotherapies, which include PD-1, PD-L1 and CTLA-4 targeted antibody therapies.
Feb 18
18 February 2025, 9:30 am to 12:30 pm
- AHPs
- Breast cancer
- Bowel cancer
- Cancer treatment
- Cervical cancer
- CNSs
- Colorectal cancer
- Gynaecological cancer
- Head and neck cancer
- Kidney cancer
- Lower GI cancers
- Lung cancer
- Melanoma
- Oesophagheal cancer
- Ovarian cancer
- Prostate Cancer
- Skin cancer
- Upper GI cancers
- Urological cancer
This course gives staff the knowledge and confidence to discuss a wide range of targeted cancer treatments and immunotherapies for solid tumours with patients and colleagues. It focuses on demystifying the scientific concepts that underpin many of the most used treatments including those that target cell communication pathways (e.g. EGFR and HER2-targeted treatments) and immune checkpoint inhibitors.
Mar 04
4 March 2025, 9:30 am to 12:30 pm
- AHPs
- Breast cancer
- Bowel cancer
- Cancer treatment
- Cervical cancer
- CNSs
- Colorectal cancer
- Gynaecological cancer
- Head and neck cancer
- Kidney cancer
- Lower GI cancers
- Lung cancer
- Melanoma
- Oesophagheal cancer
- Ovarian cancer
- Prostate Cancer
- Skin cancer
- Upper GI cancers
- Urological cancer
This course gives staff the knowledge and confidence to discuss a wide range of targeted cancer treatments and immunotherapies for solid tumours with patients and colleagues. It focuses on demystifying the scientific concepts that underpin many of the most used treatments including those that target cell communication pathways (e.g. EGFR and HER2-targeted treatments) and immune checkpoint inhibitors.
Mar 20
20 March 2025, 9:30 am to 12:30 pm
Ideal for staff who already have some knowledge of the different types of haematological cancers and focuses on the biology and genetics of haematological cancers, understanding B cell cancers and treatments for B cell cancers: CLL, B-cell NHL, ALL. The second session explores treatments for multiple myeloma, acute myeloid leukaemia, Hodgkin lymphoma and chronic myeloid leukaemia (CML) and CAR T cell therapy for ALL, NHL, myeloma
Mar 27
27 March 2025, 9:30 am to 12:30 pm
Ideal for staff who already have some knowledge of the different types of haematological cancers and focuses on the biology and genetics of haematological cancers, understanding B cell cancers and treatments for B cell cancers: CLL, B-cell NHL, ALL. The second session explores treatments for multiple myeloma, acute myeloid leukaemia, Hodgkin lymphoma and chronic myeloid leukaemia (CML) and CAR T cell therapy for ALL, NHL, myeloma
